GNRH AGONIST VERSUS HCG TO INDUCE FINAL OOCYTE MATURATION IN PATIENTS AT LOW RISK OF OHSS

被引:0
|
作者
Green, K. A. [1 ]
Healy, M. W. [1 ,2 ]
DeCherney, A. H. [1 ]
Beall, A. S. [3 ]
Chang, F. E. [3 ]
Devine, K. [3 ]
Hill, M. J. [1 ,2 ]
机构
[1] NICHHD, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA
[2] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA
[3] Shady Grove Fertil, Rockville, MD USA
关键词
D O I
10.1016/j.fertnstert.2018.02.055
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
P-25
引用
收藏
页码:E28 / E28
页数:1
相关论文
共 50 条
  • [41] GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study
    Haas, J.
    Bassil, R.
    Samara, N.
    Zilberberg, E.
    Mehta, C.
    Orvieto, R.
    Casper, R. F.
    HUMAN REPRODUCTION, 2020, 35 (07) : 1648 - 1654
  • [42] Oocyte quality and in vitro fertilization outcome in triggering with GnRH agonist versus hCG
    Bandarian, Fatemeh
    Bandarian, Mahin
    GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, 2023, 182 (04) : 196 - 201
  • [43] Optimization of oocyte retrieval rate in women undergoing ovarian stimulation for in-vitro fertilization using hCG or GnRH agonist for triggering final oocyte maturation
    Bosdou, J.
    Deligeoroglou, E.
    Pavlidi, O.
    Makedos, A.
    Mitsoli, A.
    Lainas, G.
    Lainas, T.
    Sfontouris, I.
    Malandri, M.
    Tarlatzi, T.
    Sabbaidou, D.
    Chatzimeletiou, A.
    Zepiridis, L.
    Grimbizis, G.
    Kolibianakis, E.
    HUMAN REPRODUCTION, 2020, 35 : 1415 - 1416
  • [44] GnRH agonist compared with hCG trigger for the induction of final oocyte maturation results in decreased oocyte competence in women aged 35-40 years
    Tannus, S.
    Turki, R.
    Cohen, Y.
    Son, W. Y.
    Dahan, H. M.
    HUMAN REPRODUCTION, 2017, 32 : 453 - 454
  • [45] Triggering final follicular maturation—hCG, GnRH-agonist or both, when and to whom?
    Raoul Orvieto
    Journal of Assisted Reproduction and Genetics, 2016, 33 : 1415 - 1416
  • [46] Triggering final follicular maturation: hCG, GnRH-agonist, or both, when and to whom?
    Orvieto, Raoul
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2017, 34 (09) : 1231 - 1232
  • [47] Reducing the Risk of OHSS by GnRH Agonist Triggering
    Casper, Robert F.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (12): : 4396 - 4398
  • [48] Triggering final follicular maturation: hCG, GnRH-agonist, or both, when and to whom?
    Raoul Orvieto
    Journal of Assisted Reproduction and Genetics, 2017, 34 : 1231 - 1232
  • [49] The use of gonadotropin releasing hormone (GnRH) agonist to induce oocyte maturation in high-risk patients undergoing IVF reduces the risk of ovarian hyperstimulation syndrome (OHSS) - A prospective randomized controlled study.
    Engmann, L.
    Diluigi, A.
    Schmidt, D.
    Nulsen, J.
    Maier, D.
    Benadiva, C.
    FERTILITY AND STERILITY, 2006, 86 : S118 - S118
  • [50] Reply: GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data
    Humaidan, P.
    Kol, S.
    Benadiva, C.
    Engmann, L.
    Papanikolaou, E. G.
    HUMAN REPRODUCTION UPDATE, 2012, 18 (02) : 229 - 230